Care Med And Orthopedic Shoes Inc is categorized under Orthopedic Doctors and Physicians in Van Nuys, CA .
Care Med And Orthopedic Shoes Inc was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Jachagan Davtian at the company’s single location by writing to 7020 Lennox Avenue Apartment 5, Van Nuys, California CA 91405 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Care Med And Orthopedic Shoes Inc |
Contact Person: | Jachagan Davtian |
Address: | 7020 Lennox Avenue Apartment 5, Van Nuys, California 91405 |
Annual Revenue (USD): | $100.000 to $499.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Orthopedic Doctors and Physicians |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Care Med And Orthopedic Shoes Inc was started in 0 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Jachagan Davtian for inquiries that concern Care Med And Orthopedic Shoes Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Care Med And Orthopedic Shoes Inc can be found at the coordinates as well as the street address 7020 Lennox Avenue Apartment 5 in Van Nuys, California 91405.
For its online presence, you may visit Care Med And Orthopedic Shoes Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.